PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
http://ww2.peerview.com
Gesamtlänge aller Episoden: 11 days 20 hours 8 minutes
Matthew D. Hellmann, MD - Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies
Go online to www.peerview.com/ZHD860 to view the entire programme with slides.
Anas Younes, MD - Treatment Evolution in Newly Diagnosed Hodgkin Lymphoma: A Look at the Evidence and Implications for Practice
Go online to www.peerview.com/SFS860 to view the entire programme with slides.
Reynold A. Panettieri, Jr., MD - The Role of the Eosinophil in COPD: Implications for Precision Care and Novel Treatments
Go online to www.peerview.com/UZZ860 to view the entire programme with slides.
Riccardo Lencioni, MD, FSIR, EBIR - At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma: Preparing for the Next Evolution in Multimodal Treatment
Go online to www.peerview.com/ZCA860 to view the entire programme with slides.
Emma Guttman-Yassky, MD, PhD - New Developments in Allergic and Inflammatory Diseases: Clinical Updates From San Diego and Orlando
Go online to www.peerview.com/GCS860 to view the entire programme with slides.
Paul Richardson, MD - Integrated Myeloma Management for Transplant-Eligible Patients: The Conjunction of Novel Therapeutic Platforms, Innovative Agents, and HCT
Go online to www.peerview.com/JDR860 to view the entire programme with slides.
David Miklos, MD, PhD - New Thinking on GVHD Management in HSCT Recipients: Focus on Underlying Immunology and Innovative Therapeutics
Go online to www.peerview.com/MTV860 to view the entire programme with slides.
Francisco M. Marty, MD - Refining the Management of CMV in HCT Recipients: What Does the Future Hold?
Refining the Management of CMV in HCT Recipients: What Does the Future Hold?
Stephan A. Grupp, MD, PhD - Realizing the Promise of CAR-T Cell Therapy for Leukemia and Lymphoma: Implications for Long-Term Care in the Era of Stem Cell Transplantation
Go online to www.peerview.com/HCS860 to view the entire programme with slides.
Anas Younes, MD - Treatment Innovation in Hodgkin Lymphoma: Integrating New Therapeutic Options With Autologous Transplant Across Clinical Settings
Go online to www.peerview.com/BPK860 to view the entire programme with slides.